Literature DB >> 25706341

SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy.

Anh Thu Bui1, Fanny Laurent, Maryline Havard, François Dautry, Thierry Tchénio.   

Abstract

Metastasis involves the dissemination of single or small clumps of cancer cells through blood or lymphatic vessels and their extravasation into distant organs. Despite the strong regulation of metastases development by a cell dormancy phenomenon, the dormant state of cancer cells remains poorly characterized due to the difficulty of in vivo studies. We have recently shown in vitro that clonogenicity of prostate cancer cells is regulated by a dormancy phenomenon that is strongly induced when cells are cultured both at low cell density and in a slightly hypertonic medium. Here, we characterized by RT-qPCR a genetic expression signature of this dormant state which combines the presence of both stemness and differentiation markers. We showed that both TFGβ/BMP signaling and redox imbalance are required for the full induction of this dormancy signature and cell quiescence. Moreover, reconstruction experiments showed that TFGβ/BMP signaling and redox imbalance are sufficient to generate a pattern of genetic expression displaying all characteristic features of the dormancy signature. Finally, we observed that low cell density was sufficient to activate TGFβ/BMP signaling and to generate a slight redox imbalance thus priming cells for dormancy that can be attained with a co-stimulus like hypertonicity, most likely through an increased redox imbalance. The identification of a dual regulation of dormancy provides a framework for the interpretation of previous reports showing a restricted ability of BMP signaling to regulate cancer cell dormancy in vivo and draws attention on the role of oxidative stress in the metastatic process.

Entities:  

Keywords:  ARM, Averaging Ratio Method; BSO, buthionine sulfoximine; CE, cloning efficiency; DMEM-FCS, Dulbecco Modified Essential Medium supplemented with 10% Fetal Calf Serum and penicillin-streptomycin; LD_hyper, low cell density condition in DMEM-FCS medium; LD_hypo, low cell density condition in hypotonic medium made by addition of 25% water to DMEM-FCS; MD_hyper, medium cell density condition in DMEM-FCS medium (slightly hypertonic); MD_hypo, medium cell density condition in hypotonic medium made by addition of 25% water to DMEM-FCS; NAM, Normalized Averaging Method; SMAD transcription factor; cell proliferation; cell signaling; prostate cancer; redox regulation

Mesh:

Substances:

Year:  2015        PMID: 25706341      PMCID: PMC4615032          DOI: 10.1080/15384101.2015.1014145

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  45 in total

1.  Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow.

Authors:  Reju Korah; Monika Boots; Robert Wieder
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

2.  Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.

Authors:  Wei He; David C Dorn; Hediye Erdjument-Bromage; Paul Tempst; Malcolm A S Moore; Joan Massagué
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

3.  Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.

Authors:  S Braun; C Kentenich; W Janni; F Hepp; J de Waal; F Willgeroth; H Sommer; K Pantel
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

4.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.

Authors:  L A Liotta; J Kleinerman; G M Saidel
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

5.  Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment.

Authors:  Dalit Barkan; Lara H El Touny; Aleksandra M Michalowski; Jane Ann Smith; Isabel Chu; Anne Sally Davis; Joshua D Webster; Shelley Hoover; R Mark Simpson; Jack Gauldie; Jeffrey E Green
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

6.  Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.

Authors:  Gro Wiedswang; Elin Borgen; Rolf Kåresen; Hanne Qvist; Jan Janbu; Gunnar Kvalheim; Jahn M Nesland; Bjørn Naume
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

7.  Absence of metastatic sequelae during long-term treatment of malignant ascites by peritoneo-venous shunting. A clinico-pathological report.

Authors:  D Tarin; A C Vass; M G Kettlewell; J E Price
Journal:  Invasion Metastasis       Date:  1984

8.  BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.

Authors:  Jeroen T Buijs; Cyrill A Rentsch; Geertje van der Horst; Petra G M van Overveld; Antoinette Wetterwald; Ruth Schwaninger; Niek V Henriquez; Peter Ten Dijke; Fran Borovecki; Regula Markwalder; George N Thalmann; Socrates E Papapoulos; Rob C M Pelger; Slobodan Vukicevic; Marco G Cecchini; Clemens W G M Löwik; Gabri van der Pluijm
Journal:  Am J Pathol       Date:  2007-09       Impact factor: 4.307

9.  Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs.

Authors:  Tsukasa Shibue; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-05       Impact factor: 11.205

10.  Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases.

Authors:  George N Naumov; Jason L Townson; Ian C MacDonald; Sylvia M Wilson; Vivien H C Bramwell; Alan C Groom; Ann F Chambers
Journal:  Breast Cancer Res Treat       Date:  2003-12       Impact factor: 4.872

View more
  11 in total

1.  Transient exposure to androgens induces a remarkable self-sustained quiescent state in dispersed prostate cancer cells.

Authors:  Anh Thu Bui; Meng-Er Huang; Maryline Havard; Fanny Laurent-Tchenio; François Dautry; Thierry Tchenio
Journal:  Cell Cycle       Date:  2017-04-20       Impact factor: 4.534

Review 2.  The biology and clinical implications of prostate cancer dormancy and metastasis.

Authors:  Colm Morrissey; Robert L Vessella; Paul H Lange; Hung-Ming Lam
Journal:  J Mol Med (Berl)       Date:  2015-10-21       Impact factor: 4.599

3.  The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations.

Authors:  H Endo; J Okami; H Okuyama; Y Nishizawa; F Imamura; M Inoue
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

4.  Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth.

Authors:  X Li; Y Kang; D Roife; Y Lee; M Pratt; M R Perez; B Dai; E J Koay; J B Fleming
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

Review 5.  Immunotherapy of cancer: targeting cancer during active disease or during dormancy?

Authors:  Syed Ammer Shah; Melika Zarei; Saeed H Manjili; Georgi Guruli; Xiang-Yang Wang; Masoud H Manjili
Journal:  Immunotherapy       Date:  2017-09       Impact factor: 4.196

6.  Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications.

Authors:  Xin Dong; Hui Xue; Fan Mo; Yen-Yi Lin; Dong Lin; Nelson K Y Wong; Yingqiang Sun; Scott Wilkinson; Anson T Ku; Jun Hao; Xinpei Ci; Rebecca Wu; Anne Haegert; Rebecca Silver; Mary-Ellen Taplin; Steven P Balk; Joshi J Alumkal; Adam G Sowalsky; Martin Gleave; Colin Collins; Yuzhuo Wang
Journal:  Mol Cancer Res       Date:  2022-05-04       Impact factor: 6.333

Review 7.  Recent advances in understanding the complexities of metastasis.

Authors:  Jessica L Chitty; Elysse C Filipe; Morghan C Lucas; David Herrmann; Thomas R Cox; Paul Timpson
Journal:  F1000Res       Date:  2018-08-01

Review 8.  Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy.

Authors:  Francisco Triana-Martínez; María Isabel Loza; Eduardo Domínguez
Journal:  Cells       Date:  2020-02-03       Impact factor: 6.600

Review 9.  Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan.

Authors:  Zehra Elgundi; Michael Papanicolaou; Gretel Major; Thomas R Cox; James Melrose; John M Whitelock; Brooke L Farrugia
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

Review 10.  Cancer Stem Cells-Key Players in Tumor Relapse.

Authors:  Monica Marzagalli; Fabrizio Fontana; Michela Raimondi; Patrizia Limonta
Journal:  Cancers (Basel)       Date:  2021-01-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.